Sagar Lonial
Director/Board Member en TG THERAPEUTICS, INC. .
Fortuna: 2 M $ al 31/03/2024
Perfil
Sagar Lonial is currently an Independent Director at TG Therapeutics, Inc. He is also the Department Chair-Hematology & Medical Oncology at Emory University School of Medicine and the Chief Medical Officer at Winship Cancer Institute.
Dr. Lonial obtained a doctorate degree from the University of Louisville School of Medicine.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
TG THERAPEUTICS, INC.
0.07% | 13/03/2024 | 108 878 ( 0.07% ) | 2 M $ | 31/03/2024 |
Cargos activos de Sagar Lonial
| Empresas | Cargo | Inicio |
|---|---|---|
| TG THERAPEUTICS, INC. | Director/Board Member | 29/04/2020 |
| Winship Cancer Institute | Chief Tech/Sci/R&D Officer | - |
| Emory University School of Medicine | Corporate Officer/Principal | - |
Formación de Sagar Lonial.
| University of Louisville School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| TG THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
| Winship Cancer Institute |
- Bolsa de valores
- Insiders
- Sagar Lonial
